JR
Insider selling
John R Stuelpnagel sold $1.2M of 10x Genomics, Inc. (TXG) stock
John R Stuelpnagel, Dir of 10x Genomics, Inc. (TXG), sold 20,000 shares of TXG stock worth $1.2M, per an SEC Form 4 filed Aug 13, 2026.
It was an open-market sale.
The trade happened on Aug 11, 2026, 2 days before it was made public.
TXG has moved +35.3% since the trade date, from $58.48 to $79.10 (Sep 21, 2026 close).
- Traded
- Aug 11, 2026
- Disclosed
- Aug 13, 2026
- Filing delay
- 2 days
- Price since
- +35.3%
- Role
- Dir
- Source
- SEC Form 4
More TXG insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.